Andrew Branch
About Andrew Branch
Andrew Branch is a Therapeutic Development Specialist at Bristol Myers Squibb with extensive experience in sales and product management across various pharmaceutical and consumer goods companies.
Company
Andrew Branch is currently employed at Bristol Myers Squibb as a Therapeutic Development Specialist. Bristol Myers Squibb focuses on innovative medicines for patients battling serious diseases. Andrew is likely involved in developing and refining therapeutic solutions as part of a broader team dedicated to advancing healthcare.
Title
As a Therapeutic Development Specialist at Bristol Myers Squibb, Andrew Branch's role involves working on the development and optimization of therapeutic products. His position requires close collaboration with other professionals to ensure that new treatments meet the high standards of efficacy and safety mandated by the industry.
Previous Experience at Astellas Pharma
Andrew Branch served as a Product Specialist at Astellas Pharma from 2016 to 2020. In this role, he gained experience in the pharmaceutical industry by focusing on product management and client relationships. His responsibilities included overseeing product lifecycles, market analysis, and liaising with healthcare professionals to ensure successful product adoption.
Previous Experience at Actavis Specialty Pharmaceuticals
Before joining Astellas Pharma, Andrew Branch worked at Actavis Specialty Pharmaceuticals as a Sales Representative from 2012 to 2020 in New Brunswick, Canada. His role involved direct sales, client management, and market penetration strategies. He also frequently trained new hires and took part in special industry assignments.
Education and Expertise
Andrew Branch completed his education at Acadia University, studying there from 1998 to 2003. His academic background provided him with the foundational knowledge necessary for a career in sales and pharmaceuticals. Over the years, Andrew has built a reputation for identifying new business opportunities and consistently exceeding sales targets.